Results 131 to 140 of about 2,663 (168)

Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention. [PDF]

Clin Pharmacol Ther
Shao D, Malavé JG, Rossi JS, Franchi F, Keeley EC, Angiolillo DJ, Stouffer GA, Cavallari LH, Lee CR.   +8 more
europepmc   +1 more source

Genetic ALS-Progressive Sleep Defects Precede the Onset of Clinical Disease. [PDF]

Eur J Neurol
Lang C, Guillot SJ, Knehr A, Weydt P, Dorst J, Tumani H, Ludolph AC, Dupuis L, Bolborea M.   +8 more
europepmc   +1 more source

Pharmacogenetic phenoconversion modeling of drug–drug–gene interactions on CYP2C19 activity: effects of comedication by genotype on escitalopram concentrations

Stingl J, Molden E, Hole K, Wollmann BM, Viviani R.   +4 more
europepmc   +1 more source

Epigenetic ageing and the risk of Parkinson's disease. [PDF]

J Neurol Neurosurg Psychiatry
Peng X, Flores-Torres MH, Cortese M, Peng C, Hung AY, Schwarzschild M, Ascherio A, Bjornevik K.   +7 more
europepmc   +1 more source

Design and implementation of PharMe: a mobile application to return pharmacogenomic test results to patients. [PDF]

JAMIA Open
Slosarek T, Baum J, Frost B, Genchev N, Hermann L, Kunst S, Meister C, Schmidt M, Wagner S, Mashni SM, Lippert C, Böttinger EP, Owusu Obeng A.   +12 more
europepmc   +1 more source

Decoding Prodromal Lewy Body Disease: Clinical Differences Between Isolated REM Sleep Behavior Disorder and Hyposmia With Dopamine Transporter Deficit. [PDF]

Eur J Neurol
Banerjee LV, Pasquini J, Henderson R, Pavese N, Anderson KN.   +4 more
europepmc   +1 more source

Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum. [PDF]

Eur J Nucl Med Mol Imaging
Arnaldi D, Mattioli P, Orso B, Raffa S, Lanfranchi F, Massa F, Iranzo A, Perissinotti A, Niñerola-Baizán A, Gaig C, Serradell M, Montini A, Mayà G, Muñoz-Lopetegi A, Liguori C, Fernandes M, Placidi F, Chiaravalloti A, Šonka K, Dušek P, Zogala D, Trnka J, Boeve BF, Miyagawa T, Lowe VJ, Miyamoto T, Miyamoto M, Puligheddu M, Figorilli M, Serra A, Hu MT, Klein JC, Bes F, Kunz D, Cochen De Cock V, De Verbizier D, Plazzi G, Antelmi E, Pizza F, Terzaghi M, Bossert I, Kulcsárová K, Garibotto V, Nicastro N, Lathuilière A, Bonanni L, Morbelli S, Roascio M, Arnulfo G, Pardini M.   +49 more
europepmc   +1 more source

Influence of CYP2D6 Genotypes and Phenotypes on the Plasma Levels and Clinical Response to Aripiprazole. [PDF]

Schizophr Bull
Gras C, Piras M, Ranjbar S, Grosu C, Girardin FR, Vandenberghe F, Ansermot N, Grandjean C, Kaiser S, Gamma F, Plessen KJ, von Gunten A, Conus P, Crettol S, Eap CB.   +14 more
europepmc   +1 more source

Elevated plasma neurofilament light chain in isolated REM sleep behavior disorder: Associations with neurogenic orthostatic hypotension and implications for phenoconversion. [PDF]

J Parkinsons Dis
Calculli A, Di Martino D, Grillo P, Bellini G, Gagliardi S, Capriglia E, Fazio C, Comolli D, Malomo G, Regalbuto S, Maestri M, Hoxhaj D, Bonanni E, Ceravolo R, Cerri S, Pisani A, Terzaghi M.   +16 more
europepmc   +1 more source

Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort study. [PDF]

Pharmacogenomics J
Görnert C, Scherf-Clavel M, Weber H, Roll SC, Eckert A, Reif A, Hahn M.   +6 more
europepmc   +1 more source